| Translation towards personalized medicine in Multiple Sclerosis. | |
| | |
MedLine Citation:
|
PMID: 18789804 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
In recent years the realization that the concept 'one drug fits all' - does not work, created the need to shift gears from 'treating the disease' to 'treating the patient', and implementation of 'Personalized Medicine' where treatment is tailored to the individual. In chronic and progressive diseases, such as Multiple Sclerosis (MS), the need for tailored therapeutics is especially imperative, as the consequences of an ineffective medication might be irreversible dysfunction. In recent years accumulating evidence indicates that MS is not a single disease and that patients with different disease subtypes respond differently to a medication. Environment and genetics are among the factors that determine disease subtype and activity, and the patient's response to medication. Additional factors include demographic characteristics such as gender and age, as well as chrono-biological indicators. During the last few years, advances and availability of new technologies have brought genome-wide gene expression profiling studies to many medical fields, including MS. Genomic technologies have also stimulated pharmacogenetics studies, that aim to identify genetic factors that affect response to treatment. However, pharmacogenetics information is still immature to allow its translation to clinical practice in MS. Notably, one of the major limitations in obtaining reproducible data across MS pharmacogenetics studies has been the lack of a consensus as to the appropriate method for determining clinical response. In light of the rapid advances in technology and progress in applying individualized treatment strategies in other diseases, 'Personalized Medicine' for MS seems feasible within the coming years. |
| | |
Authors:
|
Ariel Miller; Nili Avidan; Noa Tzunz-Henig; Lea Glass-Marmor; Izabella Lejbkowicz; Ron Y Pinter; Tamar Paperna |
Related Documents
:
|
7142854 - An ultrasonic head position interface for wheelchair control. 10287114 - The state of the art versus the state of the science. the diffusion of new medical tech... 10123124 - Keyless data capture: a report of the automatic identification teacher's institute. 16101424 - Nitric oxide (no)- and nitroxyl (hno)-generating diazeniumdiolates (nonoates): emerging... 1501304 - Effect of a media blitz and a threatened lawsuit on stimulant treatment. 7142854 - An ultrasonic head position interface for wheelchair control. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review Date: 2008-09-12 |
Journal Detail:
|
Title: Journal of the neurological sciences Volume: 274 ISSN: 0022-510X ISO Abbreviation: J. Neurol. Sci. Publication Date: 2008 Nov |
Date Detail:
|
Created Date: 2008-10-20 Completed Date: 2009-04-09 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0375403 Medline TA: J Neurol Sci Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 68-75 Citation Subset: IM |
Affiliation:
|
Multiple Sclerosis & Brain Research Center, Carmel Medical Center, Israel. millera@tx.technion.ac.il |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Gene Expression Profiling Genomics Humans Multiple Sclerosis / drug therapy*, genetics* Pharmaceutical Preparations Pharmacogenetics / trends* |
| Chemical | |
Reg. No./Substance:
|
0/Pharmaceutical Preparations |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A simple method for measuring force, velocity and power output during squat jump.
Next Document: Nitric oxide, polyamines and Cd-induced phytotoxicity in wheat roots.